Cost implications of malpractice and adverse events

Area of Science:

• Healthcare economics
• Infection control
• Medical malpractice

Background:

• Hospital-acquired infections (nosocomial infections) represent a significant cost to healthcare systems.
• Infection/contamination exposure was the ninth most common malpractice allegation in 1989.
• Malpractice claims related to surgical infections were particularly costly in 1990.

Purpose of the Study:

• To analyze the financial implications of hospital-acquired infections.
• To explore strategies for reducing malpractice costs associated with infections.

Main Methods:

• Analysis of malpractice claim data from 1989 and 1990.
• Estimation of the annual cost of nosocomial infections.
• Review of potential cost-reduction strategies.

Main Results:

• An estimated 5% of hospitalized patients acquire nosocomial infections, costing approximately $10 billion annually.
• Prolonged hospitalization for parenteral antibiotic treatment constitutes over 75% of these costs.
• Average malpractice claim costs for infection/contamination were nearly $34,000 in 1989, exceeding $64,000 for surgical cases in 1990.

Conclusions:

• Implementing robust infection-control programs is crucial for preventing nosocomial infections and mitigating malpractice expenses.
• Developing and utilizing safer, more effective drugs can reduce patient suffering and associated damages.
• Reducing the incidence and impact of hospital-acquired infections offers significant economic benefits to healthcare providers and patients.